Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04704323
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2020-12-21
Brief Title:
CAP-100 for Subjects With RelapsedRefractory Chronic Lymphocytic Leukemia
Sponsor:
Catapult Therapeutics
Organization:
Catapult Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-21
First Submit QC Date:
January 8 2021
Study First Post Date:
2021-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-15
Last Update Post Date:
2024-02-15
Last Update Post Date Type:
ACTUAL